Amanda Shabana

Amanda Shabana

Auto-generated profile, based on publicly available information

Amanda Shabana

Surgical Emergency Unit, John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 December 2022 in World Journal of Emergency Surgery
Verified
Journal Article
Open access
PDF file
Belinda De SimoneBelinda De Simone
Belinda De Simone
FAFikri M. Abu-Zidan
Fikri M. Abu-Zidan
ECElie Chouillard
Elie Chouillard
SSSalomone Di Saverio
Salomone Di Saverio
MSMassimo Sartelli
Massimo Sartelli
Fausto CatenaFausto Catena
Fausto Catena
Background: The incidence of the highly morbid and potentially lethal gangrenous cholecystitis was reportedly increased during the COVID-19 pandemic. The aim of the ChoCO-W study was to compare the clinical findings and outcomes of acute cholecystitis in patients who had COVID-19 disease with those who did not. Methods: Data were prospectively collected over 6 months (October 1, 2020, to April 30, 2021) with 1-month follow-up. In October 2020, Delta variant of SARS CoV-2 was isolated for the first time. Demographic and clinical data were analyzed and reported according to the STROBE guidelines. Baseline characteristics and clinical outcomes of patients who had COVID-19 were compared with those who did not. Results: A total of 2893 patients, from 42 countries, 218 centers, involved, with a median age of 61.3 (SD: 17.39) years were prospectively enrolled in this study; 1481 (51%) patients were males. One hundred and eighty (6.9%) patients were COVID-19 positive, while 2412 (93.1%) were negative. Concomitant preexisting diseases including cardiovascular diseases (p < 0.0001), diabetes (p < 0.0001), and severe chronic obstructive airway disease (p = 0.005) were significantly more frequent in the COVID-19 group. Markers of sepsis severity including ARDS (p < 0.0001), PIPAS score (p < 0.0001), WSES sepsis score (p < 0.0001), qSOFA (p < 0.0001), and Tokyo classification of severity of acute cholecystitis (p < 0.0001) were significantly higher in the COVID-19 group. The COVID-19 group had significantly higher postoperative complications (32.2% compared with 11.7%, p < 0.0001), longer mean hospital stay (13.21 compared with 6.51 days, p < 0.0001), and mortality rate (13.4% compared with 1.7%, p < 0.0001). The incidence of gangrenous cholecystitis was doubled in the COVID-19 group (40.7% compared with 22.3%). The mean wall thickness of the gallbladder was significantly higher in the COVID-19 group [6.32 (SD: 2.44) mm compared with 5.4 (SD: 3.45) mm; p < 0.0001]. Conclusions: The incidence of gangrenous cholecystitis is higher in COVID patients compared with non-COVID patients admitted to the emergency department with acute cholecystitis. Gangrenous cholecystitis in COVID patients is associated with high-grade Clavien-Dindo postoperative complications, longer hospital stay and higher mortality rate. The open cholecystectomy rate is higher in COVID compared with non -COVID patients. It is recommended to delay the surgical treatment in COVID patients, when it is possible, to decrease morbidity and mortality rates. COVID-19 infection and gangrenous cholecystistis are not absolute contraindications to perform laparoscopic cholecystectomy, in a case by case evaluation, in expert hands. Graphical
1

14 March 2022 in BMC Surgery
Verified
Journal Article
Open access
PDF file
ZSZoe Slack
Zoe Slack
MSMohamed Shams
Mohamed Shams
RARaheel Ahmad
Raheel Ahmad
RARoshneen Ali
Roshneen Ali
DADiandra Antunes
Diandra Antunes
GTGiovanni Domenico Tebala
Giovanni Domenico Tebala
Sigmoid volvulus is a common cause of emergency surgical admission. Those patients are often treated conservatively with a high rate of recurrence. We wondered if a more aggressive management might be indicated. We have reviewed data of patients diagnosed with acute sigmoid volvulus over a 2-year period. The primary endpoint was patient survival. We analysed 332 admissions of 78 patients. 39.7% underwent resection. Survival was 54.9 ± 8.8 months from the first hospitalization, irrespective of the treatment. Long-term survival was positively influenced by being female, having a low “social score”, a younger age and surgery. Multivariate analysis showed that only being female and surgery were independently associated with better survival. Early surgery may be the best approach in patients with recurrent sigmoid volvulus, as it ensures longer survival with a better quality of life, regardless of the patient’s social and functional condition.

12 January 2024 in Annals of Hepato-Biliary-Pancreatic Surgery
Verified
Journal Article
Open access
PDF file
GTGiovanni Domenico Tebala
Giovanni Domenico Tebala
ASAmanda Shabana
Amanda Shabana
MPMahul Patel
Mahul Patel
BSBenjamin Samra
Benjamin Samra
ACAlan Chetwynd
Alan Chetwynd
GBGiles Bond-Smith
Giles Bond-Smith
Giovanni Domenico Tebala, Amanda Shabana, Mahul Patel, Benjamin Samra, Alan Chetwynd, Mickaela Nixon, Siddhee Pradhan, Bara’a Elhag, Gabriel Mok, Alexandra Mighiu, Diandra Antunes, Zoe Slack, Roberto Cirocchi, Giles Bond-Smith. Ann Hepatobiliary Pancreat Surg -0001;0:. https://doi.org/10.14701/ahbps.23-112

10 November 2023
Verified
Book Chapter
Closed access
PDF file
GTGiovanni Domenico Tebala
Giovanni Domenico Tebala
ECEmanuela Ceriati
Emanuela Ceriati
RARoshneen Ali
Roshneen Ali
SBSonia Battaglia
Sonia Battaglia
FPFrancesco De Peppo
Francesco De Peppo
VVValerio Voglino
Valerio Voglino